跳至主要内容
临床试验/TCTR20200401001
TCTR20200401001Enrolling By Invitation4 期

A comparison of efficacy between combination use of methylergonovine intravenous slowly push plus oxytocin continuous infusion and carbetocin intravenous slowly push for prevent postpartum hemorrhage in cesarean section

one0 个研究点目标入组 50 人开始时间: 2020年4月1日最近更新:
适应症

试验速览

阶段
4 期
状态
Enrolling By Invitation
发起方
one
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
Female

入选标准

  • singleton pregnancy gestational age between 34-42 weeks

排除标准

  • pregnancy with
  • - eclampsia or preeclampsia
  • - hypertension
  • - coagulation disorder
  • - polycythemia
  • - blood transfusion
  • - ischemic heart disease
  • - cerebrovascular disease
  • - peripheral vascular disease
  • - placenta previa
  • - placental abruption
  • - allergy to carbetocin , oxytocin or methylergonovine
  • - cannot speak thai language
  • - fetal distress

研究者

发起方
one

相似试验